Tirzepatide is a dual agonist of glucose dependent insulin nutritional polypeptide (GIP) and glucagon like peptide-1 (GLP-1) receptors, which is being developed for the treatment of type 2 diabetes. Compared with dulaglutide, Tirzepatide has significantly better efficacy in blood glucose control and weight loss.
Manufacturing
